SUPERNUS PHARMACEUTICALS, INC. Operating Cash Flow
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Operating Cash Flow of $61.71 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-03
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$4.81M, a 108.22% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $66.52M, a 117.41% increase year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $19.86M, a 55.27% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$61.66M, a 215.22% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2025 was $47.33M, a 72.47% decline from fiscal 2024.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2024 was $171.95M, a 54.79% increase from fiscal 2023.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2023 was $111.08M, a 4.91% decline from fiscal 2022.
- SUPERNUS PHARMACEUTICALS, INC. net cash provided by (used in) operating activities for fiscal 2022 was $116.83M, a 8.10% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $61.71M 10-Q · filed 2026-08-03 | $81.58M derived: sum of 3 quarters · filed 2026-08-03 | $19.91M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $66.52M 10-Q · filed 2026-05-05 | $86.39M derived: sum of 2 quarters · filed 2026-05-05 | $24.72M derived: sum of 3 quarters · filed 2026-05-05 | $83.26M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $19.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$41.80M derived: sum of 2 quarters · filed 2026-03-02 | $16.73M derived: sum of 3 quarters · filed 2026-08-03 | $47.33M 10-K · filed 2026-03-02 | ||
| 2025-09-30 | -$61.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$3.13M derived: sum of 2 quarters · filed 2026-08-03 | $27.47M 10-Q · filed 2025-11-06 | $71.88M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $58.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $89.13M 10-Q · filed 2026-08-03 | $133.54M derived: sum of 3 quarters · filed 2026-08-03 | $187.06M derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-03-31 | $30.60M 10-Q · filed 2026-05-05 | $75.00M derived: sum of 2 quarters · filed 2026-05-05 | $128.53M derived: sum of 3 quarters · filed 2026-05-05 | $164.15M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $44.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $97.93M derived: sum of 2 quarters · filed 2026-03-02 | $133.55M derived: sum of 3 quarters · filed 2026-03-02 | $171.95M 10-K · filed 2026-03-02 | ||
| 2024-09-30 | $53.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $89.14M derived: sum of 2 quarters · filed 2025-11-06 | $127.55M 10-Q · filed 2025-11-06 | $172.50M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2024-06-30 | $35.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $74.03M 10-Q · filed 2025-08-05 | $118.98M derived: sum of 3 quarters · filed 2026-03-02 | $154.86M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2024-03-31 | $38.40M 10-Q · filed 2025-05-06 | $83.36M derived: sum of 2 quarters · filed 2026-03-02 | $119.23M derived: sum of 3 quarters · filed 2026-03-02 | $100.36M derived: sum of 4 quarters · filed 2026-03-02 | ||
| 2023-12-31 | $44.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $80.83M derived: sum of 2 quarters · filed 2026-03-02 | $61.96M derived: sum of 3 quarters · filed 2026-03-02 | $111.08M 10-K · filed 2026-03-02 | ||
| 2023-09-30 | $35.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $17.00M derived: sum of 2 quarters · filed 2024-11-04 | $66.13M 10-Q · filed 2024-11-04 | $93.69M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | -$18.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $30.25M 10-Q · filed 2024-08-06 | $57.82M derived: sum of 3 quarters · filed 2025-02-25 | $71.66M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | $49.13M 10-Q · filed 2024-05-08 | $76.69M derived: sum of 2 quarters · filed 2025-02-25 | $90.53M derived: sum of 3 quarters · filed 2025-02-25 | $161.65M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | $27.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $41.41M derived: sum of 2 quarters · filed 2025-02-25 | $112.52M derived: sum of 3 quarters · filed 2025-02-25 | $116.83M 10-K · filed 2025-02-25 | ||
| 2022-09-30 | $13.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $84.96M derived: sum of 2 quarters · filed 2023-11-08 | $89.26M 10-Q · filed 2023-11-08 | $138.03M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $71.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $75.42M 10-Q · filed 2023-08-08 | $124.18M derived: sum of 3 quarters · filed 2023-08-08 | $120.07M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $4.30M 10-Q · filed 2023-05-09 | $53.06M derived: sum of 2 quarters · filed 2023-05-09 | $48.95M derived: sum of 3 quarters · filed 2023-05-09 | $95.23M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $48.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $44.65M derived: sum of 2 quarters · filed 2023-03-09 | $90.93M derived: sum of 3 quarters · filed 2023-03-09 | $127.13M 10-K · filed 2023-03-09 | ||
| 2021-09-30 | -$4.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $42.16M derived: sum of 2 quarters · filed 2022-11-09 | $78.36M 10-Q · filed 2022-11-09 | $110.30M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | $46.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $82.47M 10-Q · filed 2022-08-08 | $114.41M derived: sum of 3 quarters · filed 2023-03-09 | $120.01M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | $36.20M 10-Q · filed 2022-05-12 | $68.13M derived: sum of 2 quarters · filed 2023-03-09 | $73.73M derived: sum of 3 quarters · filed 2023-03-09 | $165.68M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | $31.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $37.53M derived: sum of 2 quarters · filed 2023-03-09 | $129.48M derived: sum of 3 quarters · filed 2023-03-09 | $138.40M 10-K · filed 2023-03-09 | ||
| 2020-09-30 | $5.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $97.55M derived: sum of 2 quarters · filed 2021-11-05 | $106.47M 10-Q · filed 2021-11-05 | $150.26M derived: sum of 4 quarters · filed 2022-04-13 | ||
| 2020-06-30 | $91.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $100.87M 10-Q · filed 2021-08-06 | $144.66M derived: sum of 3 quarters · filed 2022-04-13 | $182.32M derived: sum of 4 quarters · filed 2022-04-13 | ||
| 2020-03-31 | $8.92M 10-Q · filed 2021-05-07 | $52.71M derived: sum of 2 quarters · filed 2022-04-13 | $90.36M derived: sum of 3 quarters · filed 2022-04-13 | $119.05M derived: sum of 4 quarters · filed 2022-04-13 | ||
| 2019-12-31 | $43.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | $81.45M derived: sum of 2 quarters · filed 2022-04-13 | $110.14M derived: sum of 3 quarters · filed 2022-04-13 | $143.13M 10-K · filed 2022-04-13 | ||
| 2019-09-30 | $37.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $66.34M derived: sum of 2 quarters · filed 2020-11-06 | $99.34M 10-Q · filed 2020-11-06 | $132.19M derived: sum of 4 quarters · filed 2021-03-08 | ||
| 2019-06-30 | $28.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-17 | $61.68M 10-Q · filed 2020-08-17 | $94.53M derived: sum of 3 quarters · filed 2021-03-08 | $156.98M derived: sum of 4 quarters · filed 2021-03-08 | ||
| 2019-03-31 | $32.99M 10-Q · filed 2020-05-15 | $65.84M derived: sum of 2 quarters · filed 2021-03-08 | $128.29M derived: sum of 3 quarters · filed 2021-03-08 | $134.85M derived: sum of 4 quarters · filed 2021-03-08 | ||
| 2018-12-31 | $32.85M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $95.30M derived: sum of 2 quarters · filed 2021-03-08 | $101.85M derived: sum of 3 quarters · filed 2021-03-08 | $128.99M 10-K · filed 2021-03-08 | ||
| 2018-09-30 | $62.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $69.00M derived: sum of 2 quarters · filed 2019-11-08 | $96.14M 10-Q · filed 2019-11-08 | $132.47M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-06-30 | $6.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $33.69M 10-Q · filed 2019-08-09 | $70.02M derived: sum of 3 quarters · filed 2020-02-28 | $109.03M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-03-31 | $27.13M 10-Q · filed 2019-05-10 | $63.47M derived: sum of 2 quarters · filed 2020-02-28 | $102.47M derived: sum of 3 quarters · filed 2020-02-28 | $128.41M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2017-12-31 | $36.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $75.34M derived: sum of 2 quarters · filed 2020-02-28 | $101.28M derived: sum of 3 quarters · filed 2020-02-28 | $114.64M 10-K · filed 2020-02-28 | ||
| 2017-09-30 | $39.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $64.95M derived: sum of 2 quarters · filed 2018-11-09 | $78.31M 10-Q · filed 2018-11-09 | $103.24M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-06-30 | $25.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $39.30M 10-Q · filed 2018-08-09 | $64.24M derived: sum of 3 quarters · filed 2019-03-01 | $92.48M derived: sum of 4 quarters · filed 2019-03-01 | ||
| 2017-03-31 | $13.36M 10-Q · filed 2018-05-10 | $38.30M derived: sum of 2 quarters · filed 2019-03-01 | $66.53M derived: sum of 3 quarters · filed 2019-03-01 | |||
| 2016-12-31 | $24.94M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $53.18M derived: sum of 2 quarters · filed 2019-03-01 | $66.81M 10-K · filed 2019-03-01 | |||
| 2016-09-30 | $28.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $41.87M 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | $13.63M 10-Q · filed 2017-08-03 | |||||
| 2015-12-31 | $19.93M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $19.35M derived: sum of 2 quarters · filed 2018-03-01 | $34.02M derived: sum of 3 quarters · filed 2018-03-01 | $34.52M 10-K · filed 2018-03-01 | $32.12M 10-K · filed 2016-03-09 | |
| 2015-09-30 | -$575.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-01-20 | $14.09M derived: sum of 2 quarters · filed 2017-01-20 | $14.60M 10-Q/A · filed 2017-01-20 | $12.19M 10-Q · filed 2015-11-09 | $20.86M derived: sum of 4 quarters · filed 2017-01-20 | |
| 2015-06-30 | $14.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $15.17M 10-Q · filed 2015-08-07 | $21.43M derived: sum of 3 quarters · filed 2017-01-20 | $16.72M derived: sum of 4 quarters · filed 2017-01-20 | ||
| 2015-03-31 | $503.00K 10-Q · filed 2015-05-06 | $6.77M derived: sum of 2 quarters · filed 2017-01-20 | $2.05M derived: sum of 3 quarters · filed 2017-01-20 | -$4.89M derived: sum of 4 quarters · filed 2017-01-20 | ||
| 2014-12-31 | $6.26M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-01-20 | $1.55M derived: sum of 2 quarters · filed 2017-01-20 | -$5.39M derived: sum of 3 quarters · filed 2017-01-20 | -$24.50M 10-K/A · filed 2017-01-20 | $7.73M 10-K · filed 2015-03-12 | |
| 2014-09-30 | -$4.71M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-01-20 | -$11.65M derived: sum of 2 quarters · filed 2017-01-20 | -$30.76M 10-Q/A · filed 2017-01-20 | $739.00K 10-Q · filed 2014-11-12 | -$40.18M derived: sum of 4 quarters · filed 2017-01-20 | |
| 2014-06-30 | -$6.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$26.04M 10-Q · filed 2015-08-07 | -$35.47M derived: sum of 3 quarters · filed 2017-01-20 | -$51.02M derived: sum of 4 quarters · filed 2017-01-20 | ||
| 2014-03-31 | -$19.10M 10-Q · filed 2015-05-06 | -$28.52M derived: sum of 2 quarters · filed 2017-01-20 | -$44.08M derived: sum of 3 quarters · filed 2017-01-20 | -$59.83M derived: sum of 4 quarters · filed 2017-01-20 | ||
| 2013-12-31 | -$9.42M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-01-20 | -$24.97M derived: sum of 2 quarters · filed 2017-01-20 | -$40.73M derived: sum of 3 quarters · filed 2017-01-20 | -$57.95M 10-K/A · filed 2017-01-20 | ||
| 2013-09-30 | -$15.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$31.30M derived: sum of 2 quarters · filed 2014-11-12 | -$48.53M 10-Q · filed 2014-11-12 | -$64.67M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-06-30 | -$15.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | -$32.98M 10-Q · filed 2014-08-12 | -$49.12M derived: sum of 3 quarters · filed 2015-03-12 | -$60.42M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-03-31 | -$17.22M 10-Q · filed 2014-05-13 | -$33.36M derived: sum of 2 quarters · filed 2015-03-12 | -$44.66M derived: sum of 3 quarters · filed 2015-03-12 | -$54.35M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2012-12-31 | -$16.14M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$27.44M derived: sum of 2 quarters · filed 2015-03-12 | -$37.13M derived: sum of 3 quarters · filed 2015-03-12 | -$47.20M 10-K · filed 2015-03-12 | ||
| 2012-09-30 | -$11.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$20.99M derived: sum of 2 quarters · filed 2013-11-13 | -$31.06M 10-Q · filed 2013-11-13 | -$39.32M derived: sum of 4 quarters · filed 2014-03-21 | ||
| 2012-06-30 | -$9.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$19.76M 10-Q · filed 2013-08-14 | -$28.02M derived: sum of 3 quarters · filed 2014-03-21 | -$37.12M derived: sum of 4 quarters · filed 2014-03-21 | ||
| 2012-03-31 | -$10.07M 10-Q · filed 2013-05-15 | -$18.33M derived: sum of 2 quarters · filed 2014-03-21 | -$27.43M derived: sum of 3 quarters · filed 2014-03-21 | -$36.45M derived: sum of 4 quarters · filed 2014-03-21 | ||
| 2011-12-31 | -$8.26M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | -$17.36M derived: sum of 2 quarters · filed 2014-03-21 | -$26.38M derived: sum of 3 quarters · filed 2014-03-21 | -$36.19M 10-K · filed 2014-03-21 | ||
| 2011-09-30 | -$9.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$18.13M derived: sum of 2 quarters · filed 2012-11-02 | -$27.93M 10-Q · filed 2012-11-02 | |||
| 2011-06-30 | -$9.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | -$18.82M 10-Q · filed 2012-08-13 | ||||
| 2011-03-31 | -$9.80M 10-Q · filed 2012-06-08 | |||||
| 2010-12-31 | -$32.54M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |